The Orphan Drug Act has catalyzed innovation in rare disease treatments, but the law’s shortcomings — particularly around ...
As AbbVie Inc. ABBV looks to plug holes in the sales of its mega-blockbuster arthritis drug Humira, newer immunology drugs will be key to the pharmaceutical giant’s future growth, analysts say. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback